Navigation Links
MUSA Technology Partners Introduces Linux/Open Source Service Desk
Date:7/29/2009

MUSA Technology Partners, a leading provider of technology products, services and support, announced today that it is now offering its Linux and Open Source support services to all businesses. While MUSA's Service Desk currently offers specifically Linux and Open Source support, the firm will be rapidly incorporating additional services over the next six months.

Cambridge, MA (PRWEB) July 29, 2009 -- MUSA Technology Partners, a leading provider of technology products, services and support, announced today that it is now offering its Linux and Open Source support services to all businesses. While MUSA's Service Desk currently offers specifically Linux and Open Source support, the firm will be rapidly incorporating additional services over the next six months.

"We at MUSA are thrilled to expand our Linux and Open Source service desk offerings to all businesses," stated Doug Lantigua, Principal of MUSA Technology Partners. "Linux and Open Source programs are quickly gaining wider acceptance, better usability and greater incorporation into various applications in diverse business settings. As a result, Linux and Open Source applications are rapidly seeing extraordinary deployment success. We expect companies in several different industries to make either a specific or universal shift to Open Source applications to reap the benefit of lower costs and higher customizability. Our decision to introduce formal support services is aimed at fulfilling the growing need for a simple and cost-effective support solution."

The Linux and Open Source Service Desk is available to clients on either a corporate account or on-demand basis. MUSA's engineers are able to utilize encrypted access methods for quick and secure remote assistance, b
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. Novel Technology Breaks Through Cancer Pain
3. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
4. Advanced Cell Technology Announces Proposed Financing
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
10. China Technology Announces New Chief Financial Officer
11. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MUSA Technology Partners Introduces Linux/Open Source Service Desk
MUSA Technology Partners Introduces Linux/Open Source Service Desk
(Date:11/24/2009)...acy endpoint has been met for patients with advanc..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - A...he "Company"), a global biopharmaceutical company ...nnounced positive efficacy data from a Phase 2 stu...AEZS-108 (formerly AN-152), in patients with advan...
(Date:11/24/2009)... 24, 2009 Arena Pharmace...hat the company is scheduled to present at the Pip...ecember 1, 2009 at 11:30 a.m. Eastern Time (8:30 a...New York City. Jack Lief, Arena,s President and Ch...overview of the company, including its clinical de...
(Date:11/24/2009)...am Connects Customers with Partners Validated to P...tek Products , Ottawa, ON...ding provider of products for biological sample co...ounced its new global partner program. The program... partner community and is designed to help partner...
(Date:11/23/2009)...9 In a provocative new study, a University of Uta...sions the major cause of global warming cannot b...or society builds the equivalent of one new nuclea...at there will be any substantial near-term departu...ioxide emission rates," says the new paper by Tim ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...6 Zounds Hearing, a unique manufacturing,and reta...th state-of-the-art,fidelity, price point and prof...sistive listening devices (ALDs) in an effort to a...s are now available in all of the Zounds Hearing,C...8. And, from November 26,2008, through December 7...
... 26 Ceregene, Inc., a biopharmaceutical,company, ...controlled Phase 2,trial of CERE-120 in 58 patient...d not demonstrate an appreciable difference betwee...he control group. Both groups showed an approximat...ary endpoint (Unified,Parkinson,s Disease Rating S...
...Nov. 26 Covaris Incorporated today,announced that... the shipment,of its 500th instrument unit and con...o accommodate this rapid business growth, Covaris ...nization as well as implementing a,50% expansion o...was built upon the proprietary and patented AFA(TM...
Other Biology Technology:Zounds Offers the Gift of Hearing This Holiday Season With a Range of New Products 2Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease 2Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease 3Covaris Installed Instrument Base Reaches 500 Units 2
(Date:11/25/2009)...Kent State University assistant professors recentl...ation (NSF) to continue research beneficial to und... $890,000. , Christopher Blackwood, assistant pr...was awarded grants to support two separate researc...ing Litter Decomposer Communities and Functions fr...
(Date:11/24/2009)...Lupus Research Institute (LRI) today named 12 new ....6 million, recognize innovative work across a bro...or their creativity, novelty, and potential to dri...at, and cure the complex disease of systemic lupus...ed lupus researchers across the nation and include...
(Date:11/24/2009)...ts that keep weakened and flabby arteries from col...months, those stents are no longer needed -- once ...sary. Previously, doctors had no choice but to lea...l Aviv University,s Department of Biomedical Engin...atform that carries drugs where they,re needed, th...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 1Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 1Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 3Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 4Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 1Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 2
...uman immunodeficiency virus (HIV-1) molecular mach...functionally-specialized layers, according to a st...ia San Diego (UCSD) Antiviral Research Center (AVR...ology. , The unprecedented genetic diversity an... efforts to eradicate the global HIV/AIDS epidemic...
...uld More Than Double its Current Revenue, Stream...care Industry, SAN JOSE, Calif., Nov. 2 Titanium...ing biometric and security,solutions provider, ann...tent to acquire China Medical Systems (OTC: CHSY),...ching, developing and marketing of specialized,sof...
...d streams in remote parts of the UK, southern Scan...singly stained brown by dissolved organic matter. ...rnational team, led by researchers from UCL (Unive...tection Agency (EPA), demonstrates that the colour...l, pre-industrial state following a decline in the...
Other Biology News:Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 2Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 3Titanium Group Signs Letter of Intent to Acquire Multimilion Dollar Medical Software Company and Its Existing Sales Network 4Don't judge a brook by its color -- brown waters are more natural 2
...Adept CE 4100 high pressure dual piston pumps, eac...nts. The ground breaking WaveQuest UV/Visible ult...ity. The WaveQuest provides a trustworthy altern... superior stability . Hence only one detector is ...
...ples may be carried out using this high pressure s...System control and data processing is provided by ...legant, powerful and very easy to use software ope... supplied detector is the ground breaking WaveQues...
Oligonucleotides from Thermo Scientific
Pyrex brand low actinic narrow mouth Erlenmeyer flask, Pyrex ST 27 stopper from Sigma-Aldrich
Biology Products: